Starling Oncology, Inc. - Common Stock (STLN)

4.9900
+0.00 (0.00%)
NASDAQ· Last Trade: Aug 7th, 9:07 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close4.990
Open-
Bid6.430
Ask6.490
Day's RangeN/A - N/A
52 Week Range4.850 - 5.290
Volume419,180
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume1,350,226

Chart

News & Press Releases

Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
CERRITOS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its quarter ended June 30, 2026 and updated it's full-year 2026 guidance.
By Starling Oncology · Via GlobeNewswire · August 6, 2026